China's Export Shift: 'New New Three' Sectors Drive Trade Growth

In the first half of 2026, China's foreign trade showed strong resilience, with total goods trade rising 16.9% to 25.47 trillion RMB. Beyond traditional exports, a new trio of high-tech sectors—robotics, artificial intelligence, and innovative drugs, dubbed the "New New Three"—has rapidly gained traction. Driven by industrial upgrading and global demand, these sectors are shifting China's export profile from labor-intensive goods to high-value, innovation-driven technologies.

China's export structure is undergoing a significant qualitative shift. The rise of the 'New New Three'—robotics, AI, and innovative drugs—suggests that China is successfully moving up the global value chain, moving beyond green energy tech into deep-tech and life sciences, which may redefine its trade relationships with developed economies.

In the first half of 2026, China's foreign trade demonstrated notable resilience amid rising global trade barriers and geopolitical tensions. According to the National Bureau of Statistics, China's total goods trade import and export value reached 25.47 trillion RMB, representing a 16.9% year-on-year increase [6a596d48deeb9b05439f9b46]. Exports grew by 13.4% to 14.73 trillion RMB [6a596d48deeb9b05439f9b46]. Beyond these headline figures, a structural shift is underway as China transitions from its traditional "Old Three" exports (apparel, furniture, and home appliances) and its green-tech "New Three" (electric vehicles, lithium batteries, and solar cells) to the "New New Three": robotics, artificial intelligence (AI), and innovative drugs [6a596d48deeb9b05439f9b46]. In the robotics sector, Chinese manufacturers are expanding their global footprint. During the first half of 2026, China's industrial robot exports grew by 18.6% year-on-year, while surgical robot exports surged 3.3-fold [6a596d48deeb9b05439f9b46]. More than 10,000 smart bionic robots were exported to over 90 countries and regions [6a596d48deeb9b05439f9b46]. This technological presence was also visible at the early 2026 Consumer Electronics Show (CES) in the United States, where Chinese companies occupied over half of the humanoid robot exhibition booths [6a596d48deeb9b05439f9b46]. The AI sector has similarly driven export growth, particularly through hardware components. Double-digit export growth in electronic and computer components contributed 6.9 percentage points to China's overall export growth in the first half of the year [6a596d48deeb9b05439f9b46]. On the production side, high-tech manufacturing value-added grew by 13.3% year-on-year, with average daily integrated circuit production exceeding 1.5 billion pieces [6a5cfc2f57d1b69d0d205f50]. On the software front, data from the API aggregation platform OpenRouter showed that during the week of June 15–21, Chinese AI models accounted for 18.81 trillion tokens of the 46.7 trillion tokens called globally, holding the top spot for eight consecutive weeks [6a596d48deeb9b05439f9b46]. Meanwhile, China's pharmaceutical sector experienced an export boom. In the first half of 2026, the total value of out-licensing (License-out) deals for Chinese innovative drugs reached approximately $110 billion, representing about 80% of the total value recorded in the entirety of 2025 [6a596d48deeb9b05439f9b46]. Chinese pharmaceutical firms, including BeiGene and Hengrui, secured eight of the top ten global pharmaceutical transactions during this period [6a596d48deeb9b05439f9b46]. This high-tech transition is supported by market diversification. China's trade with Belt and Road partner countries grew by 14.8%, while trade with Latin America and Africa rose by 16.2% and 19.6%, respectively [6a596d48deeb9b05439f9b46]. Private enterprises remained highly active, with their trade volume growing 17% to account for 57% of China's total trade value [6a596d48deeb9b05439f9b46].